Collectively, our findings demonstrate that increased expression of Evi1 in vivo leads to the development of MDS/MPN–like disease, recapitulating the characteristic features observed in MDS/MPN patients with high EVI1 expression. The gene discussed is MECOM; the disease is myeloproliferative neoplasm.